Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Genes & Diseases|August 17, 2023
Monogenic deficiency in murine intestinal Cdc42 leads to mucosal inflammation that induces crypt dysplasiaDongsheng Zhang, Wenjuan Tang, Haitao Niu, et al.
American Journal of Hematology|April 28, 2009
Elevated AF1q expression is a poor prognostic marker for adult acute myeloid leukemia patients with normal cytogeneticsCrawford J Strunk, Uwe Platzbecker, Christian Thiede, et al.
Oncotarget|June 4, 2016
MLLT11/AF1q boosts oncogenic STAT3 activity through Src-PDGFR tyrosine kinase signalingJino Park, Soojin Kim, Joongho Joh, et al.
Stem Cell Reviews and Reports|January 24, 2020
Targeting Two Antigens Associated with B-ALL with CD19-CD123 Compound Car T Cell TherapyLulu E Yan, Hongyu Zhang, Masayuki Wada, et al.
Hematological Oncology|March 2, 2011
Higher busulfan dose intensity does not improve outcomes of patients undergoing allogeneic haematopoietic cell transplantation following fludarabine, busulfan-based reduced toxicity conditioningMehdi Hamadani, Michael Craig, Gary S Phillips, et al.
Cell Death & Disease|November 7, 2025
The RNA N<sup>6</sup>-methyladenosine methylome coordinates long non-coding RNAs to mediate cancer drug resistance by activating PI3K signalingYanhong Tan, Changli Zhou, Sicheng Bian, et al.
Blood|January 23, 2014
Downregulation of RUNX1/CBFβ by MLL fusion proteins enhances hematopoietic stem cell self-renewalXinghui Zhao, Aili Chen, Xiaomei Yan, et al.
Journal of Hematology & Oncology|August 29, 2021
Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trialFarhad Ravandi, Gail J Roboz, Andrew H Wei, et al.
Oncotarget|June 17, 2015
AF1q is a novel TCF7 co-factor which activates CD44 and promotes breast cancer metastasisJino Park, Michaela Schlederer, Martin Schreiber, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 10, 2021
A Phase II Trial of Imatinib Mesylate as Maintenance Therapy for Patients With Newly Diagnosed C-kit-positive Acute Myeloid LeukemiaAnjali S Advani, William Tse, Hong Li, et al.
Pageof 9